BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1343472)

  • 1. CA-125 monitored therapy with GnRH analogue of pelvic endometriosis.
    Negri P; Ricciardelli MA; Tomasi A; Grechi E; Fortini RM
    Acta Eur Fertil; 1992; 23(4):171-4. PubMed ID: 1343472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Androgens and other hormones in buserelin therapy].
    Fuchs U; Zwirner M
    Geburtshilfe Frauenheilkd; 1991 Feb; 51(2):140-2. PubMed ID: 1904040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal changes in buserelin therapy].
    Fuchs U; Zwirner M
    Zentralbl Gynakol; 1989; 111(18):1236-40. PubMed ID: 2511705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study on finding optimal dose of a potent LHRH agonist (buserelin) for the treatment of endometriosis--multicenter trial in Japan.
    Minaguchi H; Uemura T; Shirasu K
    Prog Clin Biol Res; 1986; 225():211-25. PubMed ID: 3097667
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies].
    Raitz von Frentz M; Schweppe KW
    Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):634-9. PubMed ID: 2145192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study].
    Schindler AE; Bühler K; Mettler L; Fuchs U; Cirkel U; Ochs H; Schweppe KW; Koch R
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):569-73. PubMed ID: 8001754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclical gonadotrophin and progesterone secretion in women with minimal endometriosis.
    Williams CA; Oak MK; Elstein M
    Clin Reprod Fertil; 1986 Aug; 4(4):259-68. PubMed ID: 3096552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
    Cirkel U; Schweppe KW; Ochs H; Schneider HP
    Prog Clin Biol Res; 1986; 225():189-99. PubMed ID: 3097665
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonal and immunologic methods in the diagnosis and treatment of patients with benign ovarian tumors and endometriotic cysts.
    Adamyan LV; Fanchenko ND; Alexeyeva ML; Andreyeva YeN ; Novikov YeA ; Jahan I
    Int J Fertil; 1993; 38(2):92-8. PubMed ID: 8097504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of LHRH agonist therapy in the treatment of endometriosis (Dutch experience).
    Franssen AM; Kauer FM; Rolland R; Zijlstra JA; Willemsen WN; van 't Veen AJ
    Prog Clin Biol Res; 1986; 225():201-10. PubMed ID: 3097666
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH.
    Okuda K; Ushiroyama T; Yoshikawa M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1889-93. PubMed ID: 3145318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary report on the comparative use of buserelin (Hoe 766) and danazol in the treatment of endometriosis: the University of Southern California experience.
    Yee B
    Prog Clin Biol Res; 1986; 225():175-88. PubMed ID: 3097664
    [No Abstract]   [Full Text] [Related]  

  • 13. CA-125 spontaneous modifications through the menstrual cycle: preliminary report.
    Negri P; Condemi L; Tomasi A; Vitagliano I; Di Leo A; Andreoli M
    Acta Eur Fertil; 1989; 20(1):29-30. PubMed ID: 2506724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
    Sirimongkolkasem R; Rojanasakul A; Chailurkit LO
    J Med Assoc Thai; 1990 Feb; 73 Suppl 1():37-41. PubMed ID: 2112582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Initial results in the treatment of endometriosis with the LH-RH analog buserelin].
    Hardt W; Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Genz T; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):483-9. PubMed ID: 3093311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experiences in the treatment of endometriosis with the LH-RH analog buserelin with special reference to the post-therapy course].
    Schmidt-Gollwitzer K; Schönegg W; von Holleben H; Hardt W; Nevinny-Stickel J
    Wien Med Wochenschr; 1988 Nov; 138(21):552-6. PubMed ID: 3144097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible pituitary ovarian suppression induced by an LHRH agonist in the treatment of endometriosis--comparison of two dose regimens.
    Shaw RW; Matta W
    Clin Reprod Fertil; 1986 Oct; 4(5):329-36. PubMed ID: 3100012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of danazol in the management of endometriosis.
    Young MD; Blackmore WP
    J Int Med Res; 1977; 5 Suppl 3():86-91. PubMed ID: 913886
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.
    Lemay A; Maheux R; Faure N; Jean C; Fazekas AT
    Fertil Steril; 1984 Jun; 41(6):863-71. PubMed ID: 6427019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients.
    Franssen AM; Rolland R; Chadha DR; Willemsen WN; Vemer HM
    Eur J Obstet Gynecol Reprod Biol; 1986 Dec; 23(5-6):379-86. PubMed ID: 3100357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.